ESC Premium Access

Preprocedural neutrophil-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease

Congress Presentation

About the speaker

Doctor Hideki Wada

Juntendo University School of Medicine, Tokyo (Japan)
0 follower

71 more presentations in this session

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

Speaker: Doctor G. Chi (Boston, US)

Thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Thumbnail

Factor V Leiden related risk of thromboembolic and bleeding complications in patients with established coronary heart disease.

Speaker: Doctor B. Mahmoodi (Rotterdam, NL)

Thumbnail

Factor V Leiden and prothrombin G20210A mutations in patients with premature myocardial infarction.

Speaker: Professor L. Rallidis (Athens, GR)

Thumbnail

Angiographic and hemodynamic modifications of Myocardial Bridge during supine bicycle exercise

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)

Thumbnail

Access the full session

Poster session 2 - Coronary artery disease: from bench to bedside

Speakers: Doctor H. Wada, Doctor G. Chi, Professor P. Pignatelli Spinazzola, Doctor B. Mahmoodi, Professor L. Rallidis...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations